Spire Roding Hospital offers the Gardisil vaccine to young women from Essex, East London and beyond to help give them protection from most forms of cervical cancer. The Human Papilloma Virus (HPV) is a common virus passed on through sexual contact.
Gardisil offers young women protection against cervical cancer
Available for young women aged 16 and above, Gardisil also helps prevent genital warts and pre-cancerous cervical lesions.
According to Cancer Research UK, cervical cancer is the 11th most common form of the condition in women and affects around 3,000 women a year.
The vaccine, which is administered over a course of 3 injections in a 6 month period, offers protection against 4 types of the 'human papillomavirus' (2 of which cause 70% of cervical cancer cases, and the other 2 cause 90% of genital warts), compared to just 1 type of virus offered by alternative vaccines.
Every year 3,000 new cases of cervical cancer are diagnosed in Britain and three women under the age of 44 die from the disease every day.
Although usual screening should be continued, Gardasil helps protect against four types of human papilloma virus.
The service is led by our highly experienced clinical oncologist, Dr Sherif Raouf, and is available in a clean and comfortable private hospital environment.
Patients do not need to be referred by a GP for this service.
Read more about Spire Roding's other clinics and services.